Skip to content
RPRPRP252525

Drawing based on the label description. No photo yet.

“25 mg white to off-white, film-coated, round, biconvex, tablet of 6.5 mm, debossed with "RP" on one side and "25" on the other side”

RP 25 pill

Pill with imprint RP 25 is white, round, 6 mm and has been identified as Rilpivirine 25 mg. It is used for HIV. It is supplied by Somerset Therapeutics, LLC.

Rilpivirine 25 mg

Imprint
RP 25
Strength
25 mg
Used for
HIV
Color
White
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Somerset Therapeutics, LLC
Drug class
HIV medicine
NDC
70069-848, 70069-848-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Rilpivirine pills and guides

What is Rilpivirine used for?

Rilpivirine is used for HIV.

Medicine type
HIV medicine
Official uses from the US prescribing label

Treatment of HIV-1 in Treatment-Naïve Patients

EDURANT and EDURANT PED, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve patients 2 years of age and older and weighing at least 14 kg with plasma HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy.

Limitations of Use

  • More EDURANT treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥50 copies/mL) compared to EDURANT treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.

Treatment of HIV-1 in Combination with Cabotegravir

EDURANT is indicated in combination with VOCABRIA (cabotegravir) for short-term treatment of HIV-1 infection in adults and adolescents 12 years and older and weighing at least 35 kg who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine, for use as:

  • oral lead-in to assess the tolerability of rilpivirine prior to administration of rilpivirine extended-release injectable suspension, a component of CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension).
  • oral therapy for patients who will miss planned injection dosing with CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension).

From the FDA-approved label on DailyMed (published Sep 01, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows RP and the other side shows 25.
  • It is white, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Rilpivirine Hydrochloride

Inactive: Lactose Monohydrate, Povidone K30, Polysorbate 20, Croscarmellose Sodium, Magnesium Stearate, Hypromellose 2910 (6 Mpa.s), Ci 77891, Peg-60, Triacetin, Silicified Microcrystalline Cellulose (125 .micro.m, High-Density)

Other pills with imprint RP 2 5

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Rilpivirine pills